(Q44360560)

2 December 2017

title

Genetic and environmental risk factors for oral anticoagulant overdose (English)

1 reference

2 December 2017

1 reference

1 reference

1 reference

4

1 reference

2 December 2017

6

1 reference

2 December 2017

Christian Funck-Brentano

object named as

C Funck-Brentano

7

0 references

author name string

C Verstuyft

1

1 reference

2 December 2017

A Robert

2

1 reference

2 December 2017

S Morin

3

1 reference

2 December 2017

A Flahault

5

1 reference

2 December 2017

P Jaillon

8

1 reference

2 December 2017

L Becquemont

9

1 reference

2 December 2017

publication date

18 February 2003

1 reference

European Journal of Clinical Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

58

1 reference

2 December 2017

issue

11

1 reference

2 December 2017

page(s)

739-745

1 reference

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Clinically significant drug interactions with the oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Interindividual variability in sensitivity to warfarin--Nature or nurture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Norfloxacin does not alter warfarin's disposition or anticoagulant effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Clinically important drug interactions with anticoagulants. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Altered pharmacokinetics of R- and S-acenocoumarol in a subject heterozygous for CYP2C9*3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0538-2

The incidence and clinical significance of amiodarone and acenocoumarol interaction.

21 January 2018

1 reference

12 December 2020

Controlled vitamin K content diet for improving the management of poorly controlled anticoagulated patients: a clinical practice proposal

1 reference

12 December 2020

THE BIOLOGICAL DISAPPEARANCE RATE OF PROTHROMBIN, FACTORS VII, IX AND X FROM PLASMA IN HYPOTHYROIDISM, HYPERTHYROIDISM, AND DURING FEVER

1 reference

12 December 2020

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

12 December 2020

CYP2C9*3 allelic variant and bleeding complications

1 reference

12 December 2020

Genetic modulation of oral anticoagulation with warfarin

1 reference

12 December 2020

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

1 reference

12 December 2020

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

1 reference

12 December 2020

Allelic discrimination using fluorogenic probes and the 5' nuclease assay

1 reference

12 December 2020

Role of CYP2C9 polymorphism in losartan oxidation

1 reference

12 December 2020

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

12 December 2020

Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans

1 reference

12 December 2020

Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation

1 reference

12 December 2020

The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol

1 reference

12 December 2020

Genetic analysis of the human cytochrome P450 CYP2C9 locus

1 reference

12 December 2020

Acquired warfarin resistance and weight-reducing diet

1 reference

12 December 2020

10.1007/S00228-002-0538-2

Identifiers

DOI

1 reference

2 December 2017

1 reference